Patient Risk Preference to be Used in Clinical Trial Design

A recent project collaboration between RTI Health Solutions, the Medical Device Innovation Consortium (MDIC) and the Michael J. Fox Foundation for Parkinson’s Research (MJFF) represents the first time patient preferences on benefits and risks have been used as an explicit means to set significance levels in a clinical trial design. Learn more here. (Source: RTI International, 10/18/16)

You might also be interested in:

NICE Provides First Advice on Patient Preference Study Design February 15, 2019
Xtalks Highlights Webinar by HealthEconomics.Com,… March 8, 2019
Leveraging Technology to Reduce Costs in Clinical Trials June 30, 2019
Pharmerit Expands Market Access Support in Asia January 17, 2019
The Price of Innovation: The Role of Drug Pricing in Financing… June 19, 2019
Blog Post Spotlights Two-Sided Risk for ACOs in MSSP July 19, 2018
AMCP Foundation to Reveal Research Findings at Symposium August 22, 2018